New Delhi, Aug. 1 -- With US President Donald Trump's decision to impose 25 per cent tariffs on goods imported from India set to take effect soon, Pharmaceuticals Export Promotion Council of India Vice Chairman Bhavin Mukund Mehta has laid out multiple scenarios for the Indian pharmaceutical companies operating in the US under the new tariff regime.

"I think we are still waiting for the final outcome, which is going to come tomorrow. Then we can see exactly how the tariffs are going to be implemented and on which products, " Mehta told ANI.

Trump had announced that India's tariff rate would be effective August 1, but an executive order signed for 69 countries - with India on the list - says the new tariff rates will be applicable from A...